173 related articles for article (PubMed ID: 21620910)
21. Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.
Chang J; Chen X; Glass Z; Gao F; Mao L; Wang M; Xu Q
Acc Chem Res; 2019 Mar; 52(3):665-675. PubMed ID: 30586281
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic base editing of human hematopoietic stem cells.
Zeng J; Wu Y; Ren C; Bonanno J; Shen AH; Shea D; Gehrke JM; Clement K; Luk K; Yao Q; Kim R; Wolfe SA; Manis JP; Pinello L; Joung JK; Bauer DE
Nat Med; 2020 Apr; 26(4):535-541. PubMed ID: 32284612
[TBL] [Abstract][Full Text] [Related]
23. A mini review of biodegradable calcium phosphate nanoparticles for gene delivery.
Xie Y; Chen Y; Sun M; Ping Q
Curr Pharm Biotechnol; 2013; 14(10):918-25. PubMed ID: 24372244
[TBL] [Abstract][Full Text] [Related]
24. Peptide nucleic acid-dependent artifact can lead to false-positive triplex gene editing signals.
Ho PY; Zhang Z; Hayes ME; Curd A; Dib C; Rayburn M; Tam SN; Srivastava T; Hriniak B; Li XJ; Leonard S; Wang L; Tarighat S; Sim DS; Fiandaca M; Coull JM; Ebens A; Fordyce M; Czechowicz A
Proc Natl Acad Sci U S A; 2021 Nov; 118(45):. PubMed ID: 34732575
[TBL] [Abstract][Full Text] [Related]
25. Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing.
Li C; Psatha N; Sova P; Gil S; Wang H; Kim J; Kulkarni C; Valensisi C; Hawkins RD; Stamatoyannopoulos G; Lieber A
Blood; 2018 Jun; 131(26):2915-2928. PubMed ID: 29789357
[TBL] [Abstract][Full Text] [Related]
26. Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles.
Yu KR; Natanson H; Dunbar CE
Hum Gene Ther; 2016 Oct; 27(10):729-740. PubMed ID: 27483988
[TBL] [Abstract][Full Text] [Related]
27. Targeted correction of a thalassemia-associated beta-globin mutation induced by pseudo-complementary peptide nucleic acids.
Lonkar P; Kim KH; Kuan JY; Chin JY; Rogers FA; Knauert MP; Kole R; Nielsen PE; Glazer PM
Nucleic Acids Res; 2009 Jun; 37(11):3635-44. PubMed ID: 19364810
[TBL] [Abstract][Full Text] [Related]
28. DNA delivery to cells in culture using PNA clamps.
Giorgio TD; Wyatt SK
Methods Mol Biol; 2004; 245():53-66. PubMed ID: 14707369
[No Abstract] [Full Text] [Related]
29. Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities.
Quijano E; Bahal R; Ricciardi A; Saltzman WM; Glazer PM
Yale J Biol Med; 2017 Dec; 90(4):583-598. PubMed ID: 29259523
[TBL] [Abstract][Full Text] [Related]
30. Prime editing in hematopoietic stem cells-From
Wolff JH; Mikkelsen JG
Front Genome Ed; 2023; 5():1148650. PubMed ID: 36969373
[TBL] [Abstract][Full Text] [Related]
31. Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia.
Ye L; Wang J; Tan Y; Beyer AI; Xie F; Muench MO; Kan YW
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10661-5. PubMed ID: 27601644
[TBL] [Abstract][Full Text] [Related]
32. Biodegradable polymers as non-viral carriers for plasmid DNA delivery.
Luten J; van Nostrum CF; De Smedt SC; Hennink WE
J Control Release; 2008 Mar; 126(2):97-110. PubMed ID: 18201788
[TBL] [Abstract][Full Text] [Related]
33. Polymers for nucleic acid transfer-an overview.
Wagner E
Adv Genet; 2014; 88():231-61. PubMed ID: 25409608
[TBL] [Abstract][Full Text] [Related]
34. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.
Nicolas J; Mura S; Brambilla D; Mackiewicz N; Couvreur P
Chem Soc Rev; 2013 Feb; 42(3):1147-235. PubMed ID: 23238558
[TBL] [Abstract][Full Text] [Related]
35. Bioinspired Star-Shaped Poly(l-lysine) Polypeptides: Efficient Polymeric Nanocarriers for the Delivery of DNA to Mesenchymal Stem Cells.
Walsh DP; Murphy RD; Panarella A; Raftery RM; Cavanagh B; Simpson JC; O'Brien FJ; Heise A; Cryan SA
Mol Pharm; 2018 May; 15(5):1878-1891. PubMed ID: 29590755
[TBL] [Abstract][Full Text] [Related]
36. Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break.
Rogers GL; Chen HY; Morales H; Cannon PM
Mol Ther; 2019 Oct; 27(10):1726-1736. PubMed ID: 31540849
[TBL] [Abstract][Full Text] [Related]
37. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
38. Cellular delivery of peptide nucleic acid (PNA).
Koppelhus U; Nielsen PE
Adv Drug Deliv Rev; 2003 Feb; 55(2):267-80. PubMed ID: 12564980
[TBL] [Abstract][Full Text] [Related]
39. Nonviral Nanoparticles for CRISPR-Based Genome Editing: Is It Just a Simple Adaption of What Have Been Developed for Nucleic Acid Delivery?
Qiu M; Glass Z; Xu Q
Biomacromolecules; 2019 Sep; 20(9):3333-3339. PubMed ID: 31342740
[TBL] [Abstract][Full Text] [Related]
40. Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells.
Pavani G; Fabiano A; Laurent M; Amor F; Cantelli E; Chalumeau A; Maule G; Tachtsidi A; Concordet JP; Cereseto A; Mavilio F; Ferrari G; Miccio A; Amendola M
Blood Adv; 2021 Mar; 5(5):1137-1153. PubMed ID: 33635334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
